Opioids
in the LGBTQ+
Community

Some LGBTQ+ people may encounter discrimination and marginalization due to their sexual and/or gender identity. When internalized, this social stigma can create feelings of shame and worthlessness.

To escape these emotions, some turn to opioids for relief. LGBTQ+ youth, in particular, are more likely than their heterosexual peers to begin misusing opioids. According to a large survey of transgender youth, for instance, 35% who experienced harassment in school reported turning to substances to cope.

People within the LGBTQ+ community are more likely to have experienced hate crimes and often face significantly higher levels of traumatic childhood experiences.

All of these stressors can contribute to harmful substance use.

According to the LGBT Health Education Center, transgender medical patients have been found to have an increased risk of developing opioid dependence. Opioid therapy is the most common form of pain management prescribed by physicians after gender affirmation surgery.

Members of the LGBTQ+ community living with HIV are also often prescribed opioids for pain management.

Medication-assisted therapy (MAT) can be an effective recovery method when used in combination with therapeutic interventions. When looking for providers and treatment facilities, it’s important to verify their knowledge of the complex medical needs of the community, including but not limited to:

• Hormone replacement therapy
• HIV treatment
• Trauma recovery

Behavioral interventions are often necessary for treatment plans for LGBTQ+ community members.

Treatment for opioid use disorder has been associated with a reduction in high-risk sexual behaviors, as well as the sharing of needles.

A study of gay and lesbian alumni from various treatment programs identified three major themes for getting the most out of treatment:

1. A separate unit or wing for those who identify as LGBTQ+
2. Supportive staff
3. Staff who also identify as LGBTQ+